HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noninvasive therapy with helium-oxygen for severe bronchiolitis.

AbstractOBJECTIVE:
To determine whether noninvasive therapy using a helium-oxygen mixture reduces the use of positive-pressure ventilation in the treatment of respiratory failure caused by severe bronchiolitis.
STUDY DESIGN:
This was a multicenter, randomized, double-blind, placebo-controlled trial that recruited infants in 4 pediatric intensive care units (PICUs). A total of 39 nonintubated infants with severe bronchiolitis caused by respiratory syncytial virus (RSV) were randomly assigned within 8 hours of PICU admission to receive a helium-oxygen mixture (helium group) or an air-oxygen mixture (control group) through an inflatable head hood. The primary study outcome was the requirement for positive pressure mechanical ventilation. Results were compared using Fisher's exact test.
RESULTS:
No differences were noted between the control and helium groups with respect to age (1.0 vs 1.1 months), prematurity, or family history of asthma or smoking. Positive pressure ventilation was judged necessary for 4 of the 21 (19.0%) infants in the control group and in 4 of the 18 (22.2%) in the helium group (relative risk = 1.17; 95% confidence interval = 0.34 to 4.01).
CONCLUSIONS:
This study did not detect any differences between the patients in the helium group and the control group with respect to the rate of positive-pressure ventilation.
AuthorsJean-Michel Liet, Beatrice Millotte, Marisa Tucci, Sophie Laflammme, James Hutchison, David Creery, Thierry Ducruet, Jacques Lacroix, Canadian Critical Care Trials Group
JournalThe Journal of pediatrics (J Pediatr) Vol. 147 Issue 6 Pg. 812-7 (Dec 2005) ISSN: 0022-3476 [Print] United States
PMID16356437 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Helium
  • Oxygen
Topics
  • Bronchiolitis, Viral (therapy)
  • Canada
  • Double-Blind Method
  • Helium (therapeutic use)
  • Humans
  • Infant
  • Infant, Newborn
  • Oxygen (therapeutic use)
  • Positive-Pressure Respiration
  • Respiratory Syncytial Virus Infections (therapy)
  • Respiratory Therapy (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: